Background illustration for clinical trials search

Paid Clinical Trials Aurora

Discover 1,604 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,604

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for

GRIN-related Neurodevelopmental Disorder

Location: Aurora CO, Dallas TX, Iowa City IA, Austin TX,

Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase 3, Recruiting

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

for

Premature Infant, Chronic Respiratory Disease,

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: All

Age: 0 - 40

Code: NCT03797183

Recruiting

Minima Stent System Post- Approval Study (PAS)

for

Pulmonary Artery Stenosis, Aortic Coarctation

Location: Aurora CO, Dallas TX, Austin TX, Saint Louis MI,

Sponsor: Renata Medical

Sex: All

Age: 0+

Code: NCT06828770

Recruiting

Safety of Short-course of NSAIDs in Pediatric Patients With CKD

for

Chronic Kidney Disease, Pediatric Urology

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: All

Age: 1 - 25

Code: NCT06860711

Recruiting

Non-invasive Prediction of EArly Cardiac rEjection

for

Heart Transplant, Pediatric Heart Transplant, Rejection,

Location: Denver CO, Little Rock AR, St Louis MO, San Diego CA,

Sponsor: Vanderbilt University Medical Center

Sex: All

Age: 6 - 25

Code: NCT07770659

Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for

Ig-E Mediated Food Allergy

Location: Aurora CO, Denver CO, Colorado Springs CO, Phoenix AZ,

Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase 2, Recruiting

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for

Rhabdomyosarcoma

Location: Aurora CO, Denver CO, Salt Lake City UT, Wichita KS,

Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT07466316

Phase 3, Recruiting

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

for

Fragile X Syndrome

Location: Aurora CO, Phoenix AZ, Minneapolis MN, Irvine CA,

Sponsor: Mirum Pharmaceuticals, Inc.

Sex: Male

Age: 13 - 45

Code: NCT07209462

Phase 2, Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for

Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular,

Location: Aurora CO, Denver CO, Albuquerque NM, Salt Lake City UT,

Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 30

Code: NCT03126916

Phase 3, Recruiting

Optimal Ventilation for Cardiac Arrest

for

Cardiac Arrest (CA)

Location: Denver CO, Dallas TX, Iowa City IA, Austin TX,

Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

for

Recessive Dystrophic Epidermolysis Bullosa

Location: Aurora CO, Chicago IL, Galveston TX, Palo Alto CA

Sponsor: Abeona Therapeutics, Inc

Sex: All

Age: 0+

Code: NCT07700966

Recruiting

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

for

Severe Alopecia Areata

Location: Aurora CO, Albuquerque NM, Omaha NE, El Paso TX,

Sponsor: Pfizer

Sex: All

Age: 6 - 14

Code: NCT07029828

Phase 3, Recruiting

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for

Malignant Neoplasm

Location: Aurora CO, Salt Lake City UT, Sioux Falls SD,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT07630974

Phase 1, Phase 2, Recruiting

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

for

Pneumococcal Disease

Location: Aurora CO, West Jordan UT, Layton UT, Provo UT,

Sponsor: Pfizer

Sex: All

Age: 1 - 17

Code: NCT07660198

Phase 3, Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

for

Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL

Location: Aurora CO, Fort Worth TX, Houston TX, Indianapolis IN,

Sponsor: Allterum Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT07586618

Phase 1, Recruiting

Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

for

Down Syndrome

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: All

Age: 6 - 22

Code: NCT07598643

Phase 2, Recruiting

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

for

Diffuse Intrinsic Pontine Gliomas (DIPG), Progressive DIPG,

Location: Aurora CO, Houston TX, Seattle WA, Cincinnati OH,

Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 39

Code: NCT06838676

Phase 2, Recruiting

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

for

Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2,

Location: Aurora CO, Phoenix AZ, Flower Mound TX, Fort Worth TX,

Sponsor: Scholar Rock, Inc.

Sex: All

Age: 0 - 2

Code: NCT07047144

Phase 2, Recruiting

Bowel Continence Across the Lifespan in People With Spina Bifida

for

Spina Bifida, Neurogenic Bowel, Bowel Incontinence

Location: Denver CO, Phoenix AZ, Dallas TX, Los Angeles CA,

Sponsor: David Chu

Sex: All

Age: 5+

Code: NCT07390318

Recruiting

Childhood Cancer Survivor Study

for

Cancer

Location: Aurora CO, Fort Worth TX, Minneapolis MN, St Louis MO,

Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT01120353

Recruiting

Paid Clinical Trials Aurora

Filter results

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

Genesis Electrical Impedance Tomography (EIT): A Preliminary Study

Minima Stent System Post- Approval Study (PAS)

Safety of Short-course of NSAIDs in Pediatric Patients With CKD

Non-invasive Prediction of EArly Cardiac rEjection

Interested in new trials?

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Optimal Ventilation for Cardiac Arrest

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

Bowel Continence Across the Lifespan in People With Spina Bifida

Childhood Cancer Survivor Study